Intec Pharma Ltd. (NASDAQ:NTEC) and Krystal Biotech Inc. (NASDAQ:KRYS), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation of the two firms.
Table 1 showcases the gross revenue, earnings per share (EPS) and valuation of Intec Pharma Ltd. and Krystal Biotech Inc.
Table 2 shows Intec Pharma Ltd. and Krystal Biotech Inc.’s net margins, return on assets and return on equity.
Institutional and Insider Ownership
The shares of both Intec Pharma Ltd. and Krystal Biotech Inc. are owned by institutional investors at 39.64% and 43% respectively. Insiders held roughly 11.81% of Intec Pharma Ltd.’s shares. Insiders Competitively, held 28% of Krystal Biotech Inc. shares.
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and